ID

44766

Descrição

Documentation part: Adverse Events & Clinical Outcome Evaluation A Randomised, Observer-blind, Multicentre, Non-inferiority, Comparative, Phase III Study of the Safety and Efficacy of Topical 1% SB-275833 Ointment, Applied Twice Daily for 5 Days, versus Topical 2% Sodium Fusidate Ointment Applied Three Times Daily for 7 Days in the Treatment of Adult and Paediatric Subjects with Impetigo. ClinicalTrials.gov Identifier: NCT00133874 Other Study ID Numbers: TOC100224 Responsible Party: GlaxoSmithKline

Palavras-chave

  1. 27/06/2016 27/06/2016 -
  2. 27/06/2016 27/06/2016 -
  3. 13/04/2021 13/04/2021 - Dr. rer. medic Philipp Neuhaus
  4. 17/11/2021 17/11/2021 -
Titular dos direitos

GlaxoSmithKline

Transferido a

17 de novembro de 2021

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 4.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :


    Sem comentários

    Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

    Adverse Events & Clinical Outcome Evaluation Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874

    Adverse Events & Clinical Outcome Evaluation Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874

    Adverse Events (AE)
    Descrição

    Adverse Events (AE)

    Event (diagnosis only, otherwise sign/symptom)
    Descrição

    Event

    Tipo de dados

    text

    Alias
    UMLS CUI [1]
    C0877248
    Modified term
    Descrição

    Modified term

    Tipo de dados

    text

    Start date
    Descrição

    Start date

    Tipo de dados

    date

    Unidades de medida
    • DDMONYYYY
    Alias
    UMLS CUI [1]
    C0808070
    DDMONYYYY
    Outcome
    Descrição

    Outcome

    Tipo de dados

    text

    Alias
    UMLS CUI [1]
    C1705586
    If "Recovered/Resolved" or "Recovered/Resolved with sequelae", provide End Date and Time
    Descrição

    If "Recovered/Resolved" or "Recovered/Resolved with sequelae", provide End Date and Time

    Tipo de dados

    text

    Alias
    UMLS CUI [1]
    C0806020
    UMLS CUI [2]
    C1522314
    If "Fatal", record Date and Time of Death
    Descrição

    If

    Tipo de dados

    text

    Alias
    UMLS CUI [1]
    C1148348
    UMLS CUI [2]
    C1301931
    Maximum Intensity
    Descrição

    Maximum Intensity

    Tipo de dados

    integer

    Alias
    UMLS CUI [1,1]
    C0518690
    UMLS CUI [1,2]
    C0877248
    Actions taken with Investigational Product(s) as a Result of the AE
    Descrição

    Actions taken with Investigational Product

    Tipo de dados

    text

    Alias
    UMLS CUI [1]
    C1704758
    Did the subject withdraw from study as a result of this AE?
    Descrição

    Did the subject withdraw from study as a result of this AE?

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1]
    C0422727
    Is there a reasonable possibility that the AE may have been caused by the investigational product?
    Descrição

    Is there a reasonable possibility that the AE may have been caused by the investigational product?

    Tipo de dados

    boolean

    Alias
    UMLS CUI [1,1]
    C3641099
    UMLS CUI [1,2]
    C0877248
    Does the Adverse Event meet the definition of serious?
    Descrição

    If Yes, complete paper SAE form and fax to GSK Safety within 24 hr

    Tipo de dados

    text

    Alias
    UMLS CUI [1]
    C1710056
    If "Yes", check all that apply
    Descrição

    If "Yes", check all that apply

    Tipo de dados

    text

    Alias
    UMLS CUI [1]
    C1710056
    If "Other", please specify
    Descrição

    If "Other", please specify

    Tipo de dados

    text

    Alias
    UMLS CUI [1,1]
    C2348235
    UMLS CUI [1,2]
    C1710056
    Was SAE caused by an activity related to study participation (e.g., procedures)?
    Descrição

    Was SAE caused by an activity related to study participation (e.g., procedures)?

    Tipo de dados

    text

    Alias
    UMLS CUI [1,1]
    C1519255
    UMLS CUI [1,2]
    C3641099
    Clinical Outcome Determination (OUT)
    Descrição

    Clinical Outcome Determination (OUT)

    Clinical success
    Descrição

    Clinical success

    Tipo de dados

    text

    Alias
    UMLS CUI [1]
    C0085565
    Clinical recurrence
    Descrição

    Clinical recurrence

    Tipo de dados

    text

    Alias
    UMLS CUI [1]
    C0679254
    If "Yes", please specify if this was due to Primary or Secondary lesion:
    Descrição

    If

    Tipo de dados

    text

    Alias
    UMLS CUI [1,1]
    C3640841
    UMLS CUI [1,2]
    C1402294
    UMLS CUI [2,1]
    C3640841
    UMLS CUI [2,2]
    C1519215
    Date of recurrence
    Descrição

    Date of recurrence

    Tipo de dados

    date

    Unidades de medida
    • DDMONYYYY
    Alias
    UMLS CUI [1]
    C0807712
    DDMONYYYY
    Unable to determine clinical outcome, please specify:
    Descrição

    Unable to determine clinical outcome, please specify:

    Tipo de dados

    text

    Alias
    UMLS CUI [1,1]
    C0085565
    UMLS CUI [1,2]
    C3845108

    Similar models

    Adverse Events & Clinical Outcome Evaluation Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874

    Name
    Tipo
    Description | Question | Decode (Coded Value)
    Tipo de dados
    Alias
    Item Group
    Adverse Events (AE)
    Event
    Item
    Event (diagnosis only, otherwise sign/symptom)
    text
    C0877248 (UMLS CUI [1])
    Modified term
    Item
    Modified term
    text
    Start date
    Item
    Start date
    date
    C0808070 (UMLS CUI [1])
    Item
    Outcome
    text
    C1705586 (UMLS CUI [1])
    Code List
    Outcome
    CL Item
    Recovered/Resolved (1)
    CL Item
    Recovering/Resolving (2)
    CL Item
    Not recovered/Not resolved (3)
    CL Item
    Recovered with sequelae (4)
    CL Item
    Fatal (5)
    If "Recovered/Resolved" or "Recovered/Resolved with sequelae", provide End Date and Time
    Item
    If "Recovered/Resolved" or "Recovered/Resolved with sequelae", provide End Date and Time
    text
    C0806020 (UMLS CUI [1])
    C1522314 (UMLS CUI [2])
    If
    Item
    If "Fatal", record Date and Time of Death
    text
    C1148348 (UMLS CUI [1])
    C1301931 (UMLS CUI [2])
    Item
    Maximum Intensity
    integer
    C0518690 (UMLS CUI [1,1])
    C0877248 (UMLS CUI [1,2])
    Code List
    Maximum Intensity
    CL Item
    Mild (1)
    CL Item
    Moderate (2)
    CL Item
    Severe (3)
    CL Item
    Not applicable (X)
    Item
    Actions taken with Investigational Product(s) as a Result of the AE
    text
    C1704758 (UMLS CUI [1])
    Code List
    Actions taken with Investigational Product(s) as a Result of the AE
    CL Item
    Investigational product(s) withdrawn (1)
    CL Item
    Dose reduced (2)
    CL Item
    Doce increased (3)
    CL Item
    Dose not changed (4)
    CL Item
    Dose interrupted (5)
    CL Item
    Not applicable (X)
    Did the subject withdraw from study as a result of this AE?
    Item
    Did the subject withdraw from study as a result of this AE?
    boolean
    C0422727 (UMLS CUI [1])
    Is there a reasonable possibility that the AE may have been caused by the investigational product?
    Item
    Is there a reasonable possibility that the AE may have been caused by the investigational product?
    boolean
    C3641099 (UMLS CUI [1,1])
    C0877248 (UMLS CUI [1,2])
    Item
    Does the Adverse Event meet the definition of serious?
    text
    C1710056 (UMLS CUI [1])
    Code List
    Does the Adverse Event meet the definition of serious?
    CL Item
    No (N)
    CL Item
    Yes (Y)
    Item
    If "Yes", check all that apply
    text
    C1710056 (UMLS CUI [1])
    Code List
    If "Yes", check all that apply
    CL Item
    Results in death (A)
    CL Item
    Is life-threatening (B)
    CL Item
    Requires hospitalisation or prolongation of existing hospitalisation  (C)
    CL Item
    Results in disability/incapacity (D)
    CL Item
    Congenital anomaly/birth defect (E)
    CL Item
    Other (F)
    If "Other", please specify
    Item
    If "Other", please specify
    text
    C2348235 (UMLS CUI [1,1])
    C1710056 (UMLS CUI [1,2])
    Item
    Was SAE caused by an activity related to study participation (e.g., procedures)?
    text
    C1519255 (UMLS CUI [1,1])
    C3641099 (UMLS CUI [1,2])
    Code List
    Was SAE caused by an activity related to study participation (e.g., procedures)?
    CL Item
    No (N)
    CL Item
    Yes (Y)
    Item Group
    Clinical Outcome Determination (OUT)
    Item
    Clinical success
    text
    C0085565 (UMLS CUI [1])
    Code List
    Clinical success
    CL Item
    Yes (Y)
    CL Item
    No (N)
    Item
    Clinical recurrence
    text
    C0679254 (UMLS CUI [1])
    Code List
    Clinical recurrence
    CL Item
    Yes (Y)
    CL Item
    No (N)
    Item
    If "Yes", please specify if this was due to Primary or Secondary lesion:
    text
    C3640841 (UMLS CUI [1,1])
    C1402294 (UMLS CUI [1,2])
    C3640841 (UMLS CUI [2,1])
    C1519215 (UMLS CUI [2,2])
    Code List
    If "Yes", please specify if this was due to Primary or Secondary lesion:
    CL Item
    Primary lesion (P)
    CL Item
    Secondary lesion (S)
    Date of recurrence
    Item
    Date of recurrence
    date
    C0807712 (UMLS CUI [1])
    Unable to determine clinical outcome, please specify:
    Item
    Unable to determine clinical outcome, please specify:
    text
    C0085565 (UMLS CUI [1,1])
    C3845108 (UMLS CUI [1,2])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial